NGPS-011 - Advancing drug screening for Glioblastoma: The potential of 3D bioprinting

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: NGPS-011
• By: GAZERANI, Parisa
• Co-author(s): Ms Malén Hugsted
  Prof Ronit Satchi-Fainaro
  Prof Parisa Gazerani (Oslo Metropolitan University, Oslo, Norway)
  
• Abstract:

  Background: Glioblastoma is an aggressive brain tumor with a poor prognosis, with a five-year survival rate of less than 10%. Resistance to temozolomide, the current standard treatment, and its inability to target glioblastoma stem cells contribute to frequent disease progression and recurrence. The low success rate of oncological drugs, with only ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login